Sort by
Refine Your Search
-
, Erlangen and Bayreuth addresses this problem in a joint effort by around 20 research groups from chemistry, biology, medicine and physics. The current project is part of this effort and aims to develop a
-
at the interface between protein regulation and genome maintenance. In our research, we combine methods in genetics, molecular and cell biology with protein biochemistry and advanced genomics tools, using both
-
Description The Cluster of Excellence “CUI: Advanced Imaging of Matter”, funded by the German Federal and State Governments, combines projects in physics, chemistry, and molecular biology at
-
of creative breakthrough." The methodology combines detailed case studies, comparative pattern analyses, and quantitative data evaluation with interdisciplinary perspectives from medicine, biology, chemistry
-
), the University Hospital Cologne, the Max Planck Institute for Biology of Ageing and the Max Planck Institute for Metabolism Research. Cologne has emerged as a leading global research cluster with a stellar
-
Description The Cluster of Excellence “CUI: Advanced Imaging of Matter”, funded by the German Federal and State Governments, combines projects in physics, chemistry, and molecular biology at
-
, their achievements and productivity to the success of the whole institution. The newly DFG-funded Research Training Group ( RTG 3120 ) “Biomolecular Condensates: From Physics to Biological Functions” is developing
-
Description Bacterial biofilms are ubiquitous and play a critical role in many aspects of human life. They help us to digest food and keep our teeth clean, but they can also cause deadly hospital-acquired infections and large-scale industrial problems such as clogging oil pipes and slowing down...
-
supervision of Prof. Cicin-Sain, the head of the Department and the Speaker of the Vaccine Section of the German Immunological Society. Requirements: Master’s Degree/Diploma in Biology, Biotechnology
-
to mastering the great challenges facing society today. At the Institute of Radiopharmaceutical Cancer Research scientists (f/m/d) from the fields of physics, chemistry, biology, pharmacy, immunology, medicine